Cargando…
SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance
Recent genomic and scRNA-seq analyses of melanoma demonstrated a lack of recurrent genetic drivers of metastasis, while identifying common transcriptional states correlating with invasion or drug resistance. To test whether transcriptional adaptation can drive melanoma progression, we made use of a...
Autores principales: | Fazio, Maurizio, van Rooijen, Ellen, Dang, Michelle, van de Hoek, Glenn, Ablain, Julien, Mito, Jeffrey K, Yang, Song, Thomas, Andrew, Michael, Jonathan, Fabo, Tania, Modhurima, Rodsy, Pessina, Patrizia, Kaufman, Charles K, Zhou, Yi, White, Richard M, Zon, Leonard I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880683/ https://www.ncbi.nlm.nih.gov/pubmed/33527896 http://dx.doi.org/10.7554/eLife.64370 |
Ejemplares similares
-
The canonical HPA axis facilitates and maintains light adaptive behavior
por: Lee, Han, et al.
Publicado: (2023) -
SPRED1 deletion confers resistance to MAPK inhibition in melanoma
por: Ablain, Julien, et al.
Publicado: (2020) -
The mRNA expression of SATB1 and SATB2 in human breast cancer
por: Patani, Neill, et al.
Publicado: (2009) -
A chemical screen in zebrafish embryonic cells establishes that Akt activation is required for neural crest development
por: Ciarlo, Christie, et al.
Publicado: (2017) -
Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)